Literature DB >> 16384878

Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis.

H M Buntain1, P J Schluter, S C Bell, R M Greer, J C H Wong, J Batch, P Lewindon, C E Wainwright.   

Abstract

BACKGROUND: A study was undertaken to observe the gains in bone mass in children and adolescents with cystic fibrosis (CF) over 24 months and to examine the relationship between areal bone mineral density (aBMD) and associated clinical parameters including physical activity, nutrition, and 25-hydroxyvitamin D (25OHD).
METHODS: Areal BMD of the total body (TB), lumbar spine (LS), and total femoral neck (FNt) were repeatedly measured in 85 subjects aged 5-18 years with CF and 100 age and sex matched controls over 2 years. At each visit anthropometric variables, nutritional parameters, pubertal status, disease severity, physical activity, dietary calcium, caloric intake, and serum 25OHD were assessed and related to aBMD.
RESULTS: After adjusting for age, sex, and height Z-score, gains in LS aBMD in children (5-10 years) and TB and FNt aBMD in adolescents (11-18 years) with CF were significantly less than in controls. Lean tissue mass was significantly associated with TB and LS aBMD gains in children and adolescents and explained a significant proportion of the aBMD deficit observed. Lung function parameters were significantly associated with aBMD gains in adolescents with CF.
CONCLUSIONS: Inadequate bone mass accrual during childhood and adolescence contributes to the low bone mass observed in adults with CF. Accounting for the height discrepancy which is frequently observed in those with CF, in addition to age and sex, is important when assessing low bone mass in children and adolescents with CF. To optimise an individual's potential to acquire maximal bone mass, it is necessary to maximise nutritional status and limit the progression of chronic suppurative lung disease.

Entities:  

Mesh:

Year:  2005        PMID: 16384878      PMCID: PMC2104575          DOI: 10.1136/thx.2005.046516

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  55 in total

1.  Comparison of physical activity in adolescents with cystic fibrosis versus age-matched controls.

Authors:  M T Britto; J M Garrett; T R Konrad; J M Majure; M W Leigh
Journal:  Pediatr Pulmonol       Date:  2000-08

2.  Exercise-induced bone gain is due to enlargement in bone size without a change in volumetric bone density: a peripheral quantitative computed tomography study of the upper arms of male tennis players.

Authors:  H Haapasalo; S Kontulainen; H Sievänen; P Kannus; M Järvinen; I Vuori
Journal:  Bone       Date:  2000-09       Impact factor: 4.398

3.  Long-term effects of budesonide or nedocromil in children with asthma.

Authors:  Stanley Szefler; Scott Weiss; James Tonascia; N Franklin Adkinson; Bruce Bender; Reuben Cherniack; Michele Donithan; H William Kelly; Joseph Reisman; Gail G Shapiro; Alice L Sternberg; Robert Strunk; Virginia Taggart; Mark Van Natta; Robert Wise; Margaret Wu; Robert Zeiger
Journal:  N Engl J Med       Date:  2000-10-12       Impact factor: 91.245

4.  Effect of long-term treatment with inhaled budesonide on adult height in children with asthma.

Authors:  L Agertoft; S Pedersen
Journal:  N Engl J Med       Date:  2000-10-12       Impact factor: 91.245

5.  Augmented trochanteric bone mineral density after modified physical education classes: a randomized school-based exercise intervention study in prepubescent and early pubescent children.

Authors:  H A McKay; M A Petit; R W Schutz; J C Prior; S I Barr; K M Khan
Journal:  J Pediatr       Date:  2000-02       Impact factor: 4.406

6.  Bone mineral status in prepubertal children with cystic fibrosis.

Authors:  L A Mortensen; G M Chan; S C Alder; B C Marshall
Journal:  J Pediatr       Date:  2000-05       Impact factor: 4.406

7.  Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover.

Authors:  Steven P Conway; Susan P Wolfe; Keith G Brownlee; Helen White; Brian Oldroyd; John G Truscott; Julia M Harvey; Martin J Shearer
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

8.  Normal bone mineral density in cystic fibrosis.

Authors:  D S Hardin; R Arumugam; D K Seilheimer; A LeBlanc; K J Ellis
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

9.  Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors.

Authors:  S P Conway; A M Morton; B Oldroyd; J G Truscott; H White; A H Smith; I Haigh
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

10.  Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis.

Authors:  R M Aris; J B Renner; A D Winders; H E Buell; D B Riggs; G E Lester; D A Ontjes
Journal:  Ann Intern Med       Date:  1998-02-01       Impact factor: 25.391

View more
  8 in total

1.  UK reference data for the Hologic QDR Discovery dual-energy x ray absorptiometry scanner in healthy children and young adults aged 6-17 years.

Authors:  Kate A Ward; Rebecca L Ashby; Steven A Roberts; Judith E Adams; M Zulf Mughal
Journal:  Arch Dis Child       Date:  2006-08-30       Impact factor: 3.791

2.  Body composition and lung function in children with cystic fibrosis and meconium ileus.

Authors:  Artemis Doulgeraki; Argyri Petrocheilou; Glykeria Petrocheilou; George Chrousos; Stavros-Eleftherios Doudounakis; Athanasios G Kaditis
Journal:  Eur J Pediatr       Date:  2017-04-13       Impact factor: 3.183

Review 3.  Recognizing and treating secondary osteoporosis.

Authors:  Karen Walker-Bone
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

Review 4.  Chronic pediatric inflammatory diseases: effects on bone.

Authors:  Anuradha Viswanathan; Francisco A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2007-12-29       Impact factor: 6.514

Review 5.  Bisphosphonates for osteoporosis in people with cystic fibrosis.

Authors:  Louise S Conwell; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2014-03-14

6.  Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline.

Authors:  Brenda M Button; Christine Wilson; Ruth Dentice; Narelle S Cox; Anna Middleton; Esta Tannenbaum; Jennifer Bishop; Robyn Cobb; Kate Burton; Michelle Wood; Fiona Moran; Ryan Black; Summar Bowen; Rosemary Day; Julie Depiazzi; Katherine Doiron; Michael Doumit; Tiffany Dwyer; Alison Elliot; Louise Fuller; Kathleen Hall; Matthew Hutchins; Melinda Kerr; Annemarie L Lee; Christina Mans; Lauren O'Connor; Ranjana Steward; Angela Potter; Tshepo Rasekaba; Rebecca Scoones; Ben Tarrant; Nathan Ward; Samantha West; Dianne White; Lisa Wilson; Jamie Wood; Anne E Holland
Journal:  Respirology       Date:  2016-04-18       Impact factor: 6.424

7.  Bone and body composition analyzed by Dual-energy X-ray Absorptiometry (DXA) in clinical and nutritional evaluation of young patients with Cystic Fibrosis: a cross-sectional study.

Authors:  Vincenzina Lucidi; Carla Bizzarri; Federico Alghisi; Sergio Bella; Beatrice Russo; Graziamaria Ubertini; Marco Cappa
Journal:  BMC Pediatr       Date:  2009-09-28       Impact factor: 2.125

Review 8.  Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review.

Authors:  Stefano Stagi; Loredana Cavalli; Tiziana Cavalli; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2016-09-26       Impact factor: 2.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.